- Q1 2024 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2024$11.65 (-0.94%)Earnings
- Q4 2023 Dynavax Technologies Corp Earnings Call TranscriptFeb 22, 2024$12.44 (-0.16%)Earnings
- Dynavax Technologies Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Dynavax Technologies Corp Earnings Call TranscriptNov 02, 2023$14.07 (-0.21%)Earnings
- Dynavax Technologies Corp at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Q2 2023 Dynavax Technologies Corp Earnings Call TranscriptAug 03, 2023$13.39 (-1.11%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Dynavax Technologies Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Dynavax Technologies Corp at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Dynavax Technologies Corp Earnings Call TranscriptMay 02, 2023$10.31 (-2.00%)Earnings
- Q4 2022 Dynavax Technologies Corp Earnings Call TranscriptFeb 23, 2023$10.77 (-1.19%)Earnings
- Q3 2022 Dynavax Technologies Corp Earnings Call TranscriptNov 03, 2022$11.17 (-0.89%)Earnings
- Q2 2022 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2022$14.34 (+1.49%)Earnings
- Q1 2022 Dynavax Technologies Corp Earnings Call TranscriptMay 05, 2022$8.76 (-6.21%)Earnings
- Q4 2021 Dynavax Technologies Corp Earnings Call TranscriptFeb 28, 2022$12.26 (-1.76%)Earnings
- Q3 2021 Dynavax Technologies Corp Earnings Call TranscriptNov 04, 2021$20.76 (-0.86%)Earnings
- Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2021$9.88 (+1.44%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2021
- Q1 2021 Dynavax Technologies Corp Earnings Call TranscriptMay 06, 2021$8.88 (-0.67%)Earnings
- Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Dynavax Technologies Corp Earnings Call TranscriptFeb 25, 2021$8.16 (-13.01%)Earnings
- Q3 2020 Dynavax Technologies Corp Earnings Call TranscriptNov 05, 2020$4.13Earnings
- Q2 2020 Dynavax Technologies Corp Earnings Call TranscriptAug 06, 2020$8.82 (-1.89%)Earnings
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Dynavax Technologies Corp Earnings Call TranscriptMay 07, 2020$4.54 (-2.58%)Earnings
- Dynavax Technologies Corp - To Discuss the Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B - Conference Call TranscriptApr 30, 2020
- Q4 2019 Dynavax Technologies Corp Earnings Call TranscriptMar 11, 2020$3.07 (-18.13%)Earnings
- Q3 2019 Dynavax Technologies Corp Earnings Call TranscriptNov 06, 2019$5.23 (-2.43%)Earnings
- Q2 2019 Dynavax Technologies Corp Earnings Call TranscriptAug 07, 2019$2.99 (+3.82%)Earnings
- Q1 2019 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2019$6.53 (+0.31%)Earnings
- Q4 2018 Dynavax Technologies Corp Earnings Call TranscriptFeb 26, 2019$10.56 (+1.93%)Earnings
Dynavax Technologies Corp at JPMorgan Healthcare Conference Transcript
Hi, everyone, welcome. In terms of logistics, we're going to run through the presentation and then open it up for Q&A without much further ado, pleasue to present Dynamax.
Thank you, Luca, and thank you for JPMorgan for allowing us to present today. I'm Ryan Spencer, the CEO of Dynavax. And before I begin, I'll remind you all that we're going to make some forward-looking statements today that contain some risks and uncertainties that are detailed in our Forms 10-Q and 10-K filings, which I encourage you all to read.
Just to start off a little bit about Dynavax and who we are. We are a vaccine company focused on developing novel vaccines that help protect the world against infectious disease. We've had pretty good advancement in our core business over the last few years, which I will walk us through here.
First, our pipeline, our portfolio of assets are basically built on the backbone of our core technology, which is TLR biology, utilizing TLR9 to over the course of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)